Literature DB >> 11171678

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients.

A Zink1, J Listing, C Klindworth, H Zeidler.   

Abstract

OBJECTIVE: To describe the aims, principles, and content of the German rheumatological database and to present data on patient mix and healthcare provision for the year 1998.
METHODS: The German rheumatological database contains clinical and patient derived data of the outpatients with inflammatory rheumatic diseases seen at one of the 24 collaborative arthritis centres. The case mix, institutional context, and demographic features of 25 653 patients from the year 1998 were analysed.
RESULTS: 51% of the patients had rheumatoid arthritis, 23% seronegative spondyloarthropathies, including ankylosing spondylitis, psoriatic arthritis, and reactive arthritis, and 19% had vasculitis, including SLE (5%). The distribution of the age at onset of patients with RA with < or = 2 years' disease duration was comparable with recent incidence data from population studies. The case mix differed between university departments and rheumatology hospitals as well as individual practices. 65% of the male and 46% of the female patients at ages 18-60 were still in gainful employment, the rates of employment were 14% below the population rates for women, and 11% below those for men. 62% of all patients had seen a rheumatologist within the first year of disease, 73% within the first two years. Ankylosing spondylitis was seen in rheumatological care much later than all other diseases (only 39% within the first year). The mean number of contacts with a rheumatologist was five a year; rheumatologists in individual practices saw their patients seven times a year on the average. Together with visits to the non-specialist doctor mainly treating the patient, the mean number of visits to the doctor for a rheumatic condition was 20 a year.
CONCLUSION: Large databases like this one give information about the patient case mix in different healthcare settings, about treatment practice, and about the consequences of disease. Patients treated in specialised rheumatology units in Germany are referred earlier than in the past, which probably reflects better regional cooperation due to the implementation of arthritis centres. University departments and outpatient clinics of rheumatology hospitals contribute considerably to the specialised care of patients with arthritis and connective tissue diseases.

Entities:  

Mesh:

Year:  2001        PMID: 11171678      PMCID: PMC1753589          DOI: 10.1136/ard.60.3.199

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  [Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire].

Authors:  J Lautenschläger; W Mau; T Kohlmann; H H Raspe; F Struve; W Brückle; H Zeidler
Journal:  Z Rheumatol       Date:  1997 May-Jun       Impact factor: 1.372

2.  National database of patients visiting rheumatologists in The Netherlands: the standard diagnosis register of rheumatic diseases. A report and preliminary analysis.

Authors:  H S Miedema; S M van der Linden; J J Rasker; H A Valkenburg
Journal:  Br J Rheumatol       Date:  1998-05

3.  Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982.

Authors:  M C Hochberg
Journal:  Semin Arthritis Rheum       Date:  1990-04       Impact factor: 5.532

4.  Labour force participation among patients with rheumatoid arthritis.

Authors:  A M Chorus; H S Miedema; C J Wevers; S van Der Linden
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

5.  Effects of rheumatoid arthritis on employment and social participation during the first years of disease in The Netherlands.

Authors:  C H van Jaarsveld; J W Jacobs; A J Schrijvers; G A van Albada-Kuipers; D M Hofman; J W Bijlsma
Journal:  Br J Rheumatol       Date:  1998-08

6.  Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis.

Authors:  M M Ward
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

7.  [Health care status of rheumatic patients in rheumatologic centers 1993].

Authors:  A Zink; J Listing
Journal:  Gesundheitswesen       Date:  1996-12

8.  Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness.

Authors:  M E Suarez-Almazor; C L Soskolne; L D Saunders; A S Russell
Journal:  J Rheumatol       Date:  1995-05       Impact factor: 4.666

9.  Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989.

Authors:  C E Dugowson; T D Koepsell; L F Voigt; L Bley; J L Nelson; J R Daling
Journal:  Arthritis Rheum       Date:  1991-12

10.  [A cooperative model of the German Ministry of Health funded rheumatic disease centers].

Authors:  H Zeidler
Journal:  Z Rheumatol       Date:  1995 Jul-Aug       Impact factor: 1.372

View more
  39 in total

Review 1.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 2.  Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.

Authors:  Grant C Hughes; Divaker Choubey
Journal:  Nat Rev Rheumatol       Date:  2014-08-26       Impact factor: 20.543

3.  Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study.

Authors:  P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris
Journal:  Clin Rheumatol       Date:  2005-04-29       Impact factor: 2.980

4.  Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.

Authors:  Peter K Schädlich; Henning Zeidler; Angela Zink; Erika Gromnica-Ihle; Matthias Schneider; Christoph Straub; Josef G Brecht; Eduard Huppertz
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Definition of disease duration in ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Jon Erlendsson
Journal:  Rheumatol Int       Date:  2007-12-12       Impact factor: 2.631

6.  Vertebral body corner oedema vs gadolinium enhancement as biomarkers of active spinal inflammation in ankylosing spondylitis.

Authors:  Y-X J Wang; J F Griffith; M Deng; T K Li; L-S Tam; V W Y Lee; K K C Lee; E K Li
Journal:  Br J Radiol       Date:  2012-05-17       Impact factor: 3.039

Review 7.  [Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database].

Authors:  K Albrecht; J Callhoff; A Zink
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

8.  A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations.

Authors:  Filip Van den Bosch
Journal:  Clin Rheumatol       Date:  2009-12-03       Impact factor: 2.980

9.  Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis.

Authors:  Rachel Knevel; Saskia le Cessie; Chikashi C Terao; Kamil Slowikowski; Jing Cui; Tom W J Huizinga; Karen H Costenbader; Katherine P Liao; Elizabeth W Karlson; Soumya Raychaudhuri
Journal:  Sci Transl Med       Date:  2020-05-27       Impact factor: 17.956

10.  Clinical Case Registries: simultaneous local and national disease registries for population quality management.

Authors:  Lisa I Backus; Sergey Gavrilov; Timothy P Loomis; James P Halloran; Barbara R Phillips; Pamela S Belperio; Larry A Mole
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.